COMMUNIQUÉS West-GlobeNewswire

Parexel Earns Prestigious Society for Clinical Research Sites Eagle Award for Second Consecutive Year

30/09/2024 - 16:00

Global investigative sites recognize Parexel’s commitment to strong site relationships and patients DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Parexel , one of the world’s largest clinical research organizations ( [...]

UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

30/09/2024 - 15:48

ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir ™ consumer app with Apple and Android smartwatches. [...]

AssureCare Welcomes Stacy Mountain as Vice President of Sales

30/09/2024 - 15:45

CINCINNATI, Sept. 30, 2024 (GLOBE NEWSWIRE) -- AssureCare , a leading provider of Population Health Management solutions, is proud to welcome Stacy Mountain as the new Vice President of Sales. Stacy will lead the [...]

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

30/09/2024 - 15:31

Chief Scientific Officer, Hamid Khoja, Ph.D., to provide update on Psoriasis and Wound Care programs HOUSTON, Sept. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage [...]

Drs. Javier, Perez, and Roth Collaborate with Castle Connolly Private Health Partners to Create Joint Concierge Program, Precision Concierge Physicians

30/09/2024 - 15:30

Precision Concierge Physicians — for patients who desire a personalized approach to their healthcare NAPLES, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Castle Connolly Private Health Partners, LLC (CCPHP), a leader in [...]

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

30/09/2024 - 15:25

FDA confirm s that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical [...]

UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

30/09/2024 - 15:23

The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, [...]

Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting

30/09/2024 - 15:20

Responder Analyses Show Treatment with Aficamten Demonstrated Improvements on Multiple Assessments of Clinical Significance to Cardiologists Results Simultaneously Published in the Journal of the American College of [...]

Sonnet BioTherapeutics Announces Launch of CEO Corner Platform

30/09/2024 - 15:00

CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Provides interested parties the ability to ask questions and submit topics for future [...]

MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)

30/09/2024 - 15:00

Academic group to receive a total of $22 million for the trial LA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the [...]

AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering

30/09/2024 - 15:00

OCALA, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional [...]

Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules

30/09/2024 - 14:30

SALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly-owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]

Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference

30/09/2024 - 14:30

CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]

New 3-Year Skeletal Dynamics Data for Adults with Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide) Presented at ASBMR 2024

30/09/2024 - 14:30

COPENHAGEN, Denmark, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) shared 3-year results from the Company’s ongoing Phase 2 PaTH Forward Trial of 57 adults with hypoparathyroidism showing that [...]

Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference

30/09/2024 - 14:30

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for [...]

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

30/09/2024 - 14:30

Tim Adams to serve as Independent Board Director FORT LAUDERDALE, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative [...]

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

30/09/2024 - 14:30

Confirms the Company on Track for FDA 510(k) Submission by end of 2024 Completes All IDE required Tests and Receives Final IDE Approval from the FDA for the ACCESS-PVI Study BRAINTREE, Mass., Sept. 30, 2024 (GLOBE [...]

GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory Conditions

30/09/2024 - 14:30

Company continues to advance an innovative pipeline of NKT cell regulators for the treatment of high-value inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. ( [...]

Ascendis Pharma Announces Submission of Supplemental Biologics License Application to FDA for TransCon™ hGH for the Treatment of Adults with Growth Hormone Deficiency

30/09/2024 - 14:30

COPENHAGEN, Denmark, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food & Drug Administration [...]